These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2671428

  • 1. [Effects of ceftriaxone on severe infectious complications in hematological disorders. Tohkai Research Group on Infections in Hematological Disorders].
    Mitomo Y, Nitta M, Kodama H, Kobayashi M, Ikeda Y, Kodera Y, Matsushita T, Ohara K, Kamiya O, Shirakawa S.
    Jpn J Antibiot; 1989 Apr; 42(4):938-47. PubMed ID: 2671428
    [Abstract] [Full Text] [Related]

  • 2. [Ceftriaxone as a single agent in empirical therapy of infection in patients with hematologic disorders. Hanshin Infection Study Group].
    Kuyama J, Yonezawa T, Kageyama T, Ohyabu H, Kitani T, Taniguchi N, Masaoka T, Shibata H, Yasunaga K, Fujitake H.
    Jpn J Antibiot; 1989 Apr; 42(4):930-7. PubMed ID: 2671427
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of the efficacy of ceftriaxone in acute suppurative otitis media and acute exacerbation of chronic suppurative otitis media. A comparative study with cefotiam as the control].
    Baba S, Mori Y, Suzuki K, Unno T, Kawabori S, Yanai T, Nonaka S, Takasaka T, Awataguchi T, Furuuchi I.
    Jpn J Antibiot; 1989 Jan; 42(1):212-47. PubMed ID: 2523493
    [Abstract] [Full Text] [Related]

  • 4. [Clinical evaluation of imipenem/cilastatin sodium in infectious complications of hematological malignancies. Tohkai Research Group on Infections in Hematological Disorders].
    Naito K, Kobayashi M, Okumura M, Ikeda Y, Mitomo Y, Oguri T, Tanaka M, Ohara K, Kodera Y, Ohno R.
    Jpn J Antibiot; 1990 Aug; 43(8):1371-80. PubMed ID: 2283705
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic effect of ceftizoxime on severe infectious complications in blood disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
    Shimizu S, Hirano M, Shirakawa S, Minami N, Ohno R, Murase T, Yamamoto M, Mitomo Y, Yamada K, Shiku H.
    Jpn J Antibiot; 1984 Dec; 37(12):2494-505. PubMed ID: 6098742
    [Abstract] [Full Text] [Related]

  • 6. [Effects of ceftriaxone on infections during the perinatal period].
    Chimura T, Watanabe T, Oda T.
    Jpn J Antibiot; 1988 Mar; 41(3):306-11. PubMed ID: 3404648
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy of ceftriaxone against infections in the field of obstetrics and gynecology].
    Chimura T, Morisaki N, Matsuo M.
    Jpn J Antibiot; 1988 Jun; 41(6):641-5. PubMed ID: 3221429
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy and safety of cefbuperazone in severe infections complicating hematologic diseases Hanshin Infection Study Group].
    Kageyama T, Ohyabu H, Masaoka T, Shibata H, Nagai K, Kitani T, Horiuchi A, Kawagoe H, Yasunaga K, Yonezawa T.
    Jpn J Antibiot; 1988 Mar; 41(3):312-21. PubMed ID: 3043032
    [Abstract] [Full Text] [Related]

  • 9. [Clinical studies on ceftriaxone in respiratory tract infections. CTRX Study Group].
    Shimada K, Kimura H, Kudoh S, Mohri M, Shiraishi T, Amano Y, Kurashima A, Uzawa T, Hisada T, Nagata T.
    Jpn J Antibiot; 1993 Feb; 46(2):184-91. PubMed ID: 8331779
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation on ceftriaxone administered intravenously in neonates].
    Nakazawa S, Satoh H, Narita A, Suzuki H, Nakazawa S, Matsumoto K, Nakanishi Y, Niino K, Chikaoka H, Kamigaki M.
    Jpn J Antibiot; 1988 Mar; 41(3):225-35. PubMed ID: 3404643
    [Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
    Minami N, Uno N, Shirakawa S, Ohno R, Okumura M, Yamamoto M, Mitomo Y, Hirano M, Shimizu S, Yamada K.
    Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacokinetic and clinical evaluation of ceftriaxone in neonates and premature infants].
    Toyonaga Y, Sugita M, Hori M.
    Jpn J Antibiot; 1988 Mar; 41(3):244-61. PubMed ID: 3404645
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacokinetics and clinical evaluation of ceftriaxone in neonates].
    Fujii R, Hashira S, Sakata H, Inyaku F, Fujita K, Maruyama S, Yoshioka H, Nakazawa S, Satoh H, Narita A.
    Jpn J Antibiot; 1988 Sep; 41(9):1237-50. PubMed ID: 3071615
    [Abstract] [Full Text] [Related]

  • 14. [Clinical investigation of the therapeutic effects of cefmenoxime in the treatment of infections complicated by hematological diseases].
    Kozuru M, Kurata T, Uike N, Niho Y, Shibuya T, Otsuka T, Yamano Y, Hirota Y, Nishimura J, Katsuno M.
    Jpn J Antibiot; 1986 Mar; 39(3):701-12. PubMed ID: 3488422
    [Abstract] [Full Text] [Related]

  • 15. [Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders].
    Urabe A, Takaku F, Mizoguchi H, Nomura T, Aoki N, Yamaguchi H, Mutoh Y, Miura Y, Toyama K, Hirashima K.
    Jpn J Antibiot; 1990 Oct; 43(10):1713-22. PubMed ID: 2086813
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetic and clinical evaluations of ceftriaxone in neonates and premature infants].
    Motohiro T, Oda K, Aramaki M, Tanaka K, Kawakami A, Shimada Y, Koga T, Tomita S, Sakata Y, Fujimoto T.
    Jpn J Antibiot; 1988 Mar; 41(3):276-305. PubMed ID: 3404647
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic effect of ticarcillin against severe infection in patients with hematologic malignancy (author's transl)].
    Tsubakio T, Kitani T, Nagai K, Kanamaru A, Horiuchi A, Hasegawa H, Masaoka T, Shibata H, Kawagoe H, Shinohara Y, Yoshioka K, Kitawaki T, Nasu T.
    Jpn J Antibiot; 1981 Nov; 34(11):1451-6. PubMed ID: 7334579
    [Abstract] [Full Text] [Related]

  • 18. [Therapeutic effectiveness of ceftizoxime on severe infections associated with hematologic disorders].
    Kanamaru A, Nagai K, Masaoka T, Shibata H, Kitani T, Taniguchi N, Horiuchi A, Hasegawa H, Kawagoe H, Hirata M.
    Jpn J Antibiot; 1984 Jan; 37(1):136-44. PubMed ID: 6328059
    [Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of ceftriaxone in the treatment of neonatal infections].
    Okura K, Yamamoto H, Yamaoka K, Kubo K, Mitsuyoshi I, Haruta T, Kobayashi Y.
    Jpn J Antibiot; 1988 Feb; 41(2):152-64. PubMed ID: 3286924
    [Abstract] [Full Text] [Related]

  • 20. [Clinical effects of cefodizime in severe infections complicated with hematological diseases. Hanshin Infection Study Group].
    Teshima H, Masaoka T, Hiraoka A, Horiuchi A, Hasegawa H, Kitani T, Tagawa S, Yonezawa T, Kanayama Y, Take H.
    Jpn J Antibiot; 1992 Oct; 45(10):1295-304. PubMed ID: 1479681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.